STERLING BALLOON DILATATION CATHETER
Report
- Report Number
- 2134265-2013-01742
- Event Type
- Injury
- Date Received
- March 26, 2013
- Report Date
- February 27, 2013
- Manufacturer
- BOSTON SCIENTIFIC - MAPLE GROVE
- Product Code
- DQY
- PMA / PMN Number
- K053118
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- ES
- Reporter Occupation
- PHYSICIAN
Narratives
CITATION: DIAZ, MARIA LOURDES. ET AL. (2010). CRYOPLASTY VERSUS CONVENTIONAL ANGIOPLASTY IN FEMOROPOPLITEAL ARTERIAL RECANALIZATION: 3-YEAR ANALYSIS OF REINTERVENTION-FREE SURVIVAL BY TREATMENT RECEIVED. SPRINGER SCIENCE+BUSINESS MEDIA, LLC AND THE CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGICAL SOCIETY OF EUROPE. (CIRSE). 2010. DEVICE EVALUATED BY MFR: THE COMPLAINT DEVICE WAS NOT RECEIVED FOR ANALYSIS; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. THE BATCH NUMBER IS UNKNOWN; THEREFORE THE MANUFACTURING RECORDS FOR THE COMPLAINT DEVICE COULD NOT BE REVIEWED. THE ROOT CAUSE IS ANTICIPATED PROCEDURAL COMPLICATIONS AS THIS EVENT IS A KNOWN PHYSIOLOGICAL EFFECT OF THE PROCEDURE AND IS NOTED WITHIN THE DFU. (B)(4).
SAME CASE AS 2134265-2013-01830, 2134265-2013-01740, 2134265-2013-01829. IT WAS REPORTED VIA A JOURNAL ARTICLE THAT DURING A CRYOPLASTY PROCEDURE AN ARTERIAL DISSECTION OCCURRED. ANGIOPLASTY WAS PERFORMED WITH A STERLING BALLOON CATHETER. BALLOON SIZES WERE CHOSEN TO EQUAL THE SIZE OF THE NEAREST NORMAL VESSEL. BALLOONS WERE INFLATED WITH 8ATMS FOR 30 - 120 SECONDS. IN CASE OF RESIDUAL STENOSIS OR HEMODYNAMICALLY RELEVANT DISSECTION, THE BALLOON WAS AGAIN INFLATED FOR 3 - 5 MINUTES. IN CASE OF PERSISTENT ANGIOPLASTY FAILURE, A SELF-EXPANDABLE STENT WAS PLACED. STENTS WERE OVERSIZED TO UP TO 1MM COMPARED TO THE REFERENCE VESSEL DIAMETER.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 124408 | STERLING BALLOON DILATATION CATHETER | CATHETER, PERCUTANEOUS | DQY | BOSTON SCIENTIFIC - MAPLE GROVE | UNK413 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other |